Intravenous basic fibroblast growth factor decrease brain injury resulting from focal ischemia in cats

Stroke

Volumn 28, Issue 3, 1997, Pages 609-616

  Bethel, Ameil ^a   Kirsch, Jeffrey R ^a   Koehler, Raymond C ^a   Finklestein, Seth P ^a,b   Traystman, Richard J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cats; cerebral blood flow; growth factors; middle cerebral artery occlusion; neuroprotection; somatosensory evoked potentials

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; CAT; CONTROLLED STUDY; EVOKED SOMATOSENSORY RESPONSE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030932239     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.3.609     Document Type: Article

References (35)

1. Finklestein SP, Apostolides PJ, Caday CG, Prosser J, Philips MF, Klagsbrum M. Increased basic fibroblast growth factor (bFGF) immunoreactivity at the site of focal brain wounds. Brain Res. 1988;460:253-259.
2. Takami K, Iwane M, Kiyota Y, Miyamoto M, Tsukuda R, Shiosaka S. Increase of basic tibroblast growth factor immunoreactivity and its mRNA level in rat brain following transient forebrain ischemia. Exp Brain Res. 1992;90:1-10.
3. Anderson KJ, Dam D. Lee S, Cotman CW. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature. 1988;332:360-361.
4. Akaneya Y, Enokido Y, Takahashi M, Hatanaka H. In vitro model of hypoxia: basic fibroblast growth factor can rescue cultured CNS neurons from oxygen-deprived cell death. J Cereb Blood Flow Metab. 1993;13:1029-1032.
5. Yamada K, Kinoshita A, Kohmura E, Sakaguchi T, Taguchi J, Kataoka K, Hayakawa T. Basic fibroblast growth factor prevents thalamic degeneration after cortical infarction. J Cereb Blood Flow Metab. 1991;11:472-478.
6. Koketsu N, Berlove DJ, Moskowitz MA, Kowall NW, Caday CG, Finklestein SP. Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats. Ann Neurol. 1994;35:451-457.
7. Nakata N, Kato H, Kogure K. Protective effects of basic fibroblast growth factor against hippocampal neuronal damage following cerebral ischemia in the gerbil. Brain Res. 1993;605:354-356.
8. Wen T-C, Matsuda S, Yoshimura H, Aburaya J, Kushihata F, Sakanaka M. Protective effect of basic fibroblast growth factor-heparin and neurotoxic effect of platelet factor 4 on ischemic neuronal loss and learning disability in gerbils. Neuroscience. 1995; 65:513-521.
9. MacMillan V, Walton-Roche K, Davis J. Acidic fibroblast growth factor infusion reduces ischemic CA1 hippocampal damage in gerbil. Can J Neurol Sci. 1993;20:37-40.
10. Nozaki K, Finklestein SP, Beal MF. Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats. Cereb Blood Flow Metab. 1993;13:221-228.
11. Rosenblatt S, Irikura K, Caday CG, Finklestein SP, Moskowitz MA. Basic fibroblast growth factor dilates rat pial arterioles. J Cereb Blood Flow Metab. 1994;14:70-74.
12. Tanaka R, Miyasaka Y, Yada K, Ohwada T, Kameya T. Basic fibroblast growth factor increases regional cerebral blood flow and reduces infarct size after experimental ischemia in a rat model. Stroke. 1995;26:2154-2159.
13. Fisher M, Meadows M-E, Do T, Weise J, Trubetskoy V, Charette M, Finklestein SP. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1995;15: 953-959.
14. Matsumiya N, Koehler RC, Traystman RJ. Consistency of cerebral blood flow and evoked potential alterations with reversible focal ischemia in cats. Stroke. 1990;21:908-916.
15. Matsumiya N, Koehler RC, Kirsch JR, Traystman RJ. Conjugated superoxide dismutase reduces extent of caudate injury after transient focal ischemia in cats. Stroke. 1991;22:1193-1200.
16. Heymann MA, Payne BD, Hoffman JI, Rudolph AM. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis. 1977;20:55-79.
17. O'Brien MD, Waltz AG. Transorbital approach for occluding the middle cerebral artery without craniectomy. Stroke. 1973;4:201-206.
18. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17:1304-1308.
19. Cole DJ, Drummond JC, Ghazal EA, Shapiro HM. A reversible component of cerebral injury as identified by the histochemical stain 2,3,5-triphenyltetrazolium chloride (TTC). Acta Neuropathol (Berl). 1990;80:152-155.
20. Takeshima R, Kirsch JR, Koehler RC, Gomoll AW, Traystman RJ. Monoclonal leukocyte antibody (MoAb 60.3) does not decrease injury following transient focal cerebral ischemia in cats. Stroke. 1992;23:247-252.
21. Yazaki N, Hosoi Y, Kawabata K, Miyake A, Minami M, Satoh M, Ohta M, Kawasaki T, Itoh N. Differential expression patterns of mRNAs for members of the fibroblast growth factor receptor family, FGFR-1 - FGFR-4, in rat brain. J Neurosci Res. 1994;37:445-452.
22. Lippoldt A, Andbjer B, Rosen L, Richter E, Ganten D, Cao Y, Pettersson RF, Fuxe K. Photochemically induced focal cerebral ischemia in rat: time dependent and global increase in expression of basic fibroblast growth factor mRNA. Brain Res. 1993;625:45-56.
23. Yamada E, Kataoka H, Chue C-H, Hazama F. Expression of basic fibroblast growth factor in astrocytes at the site of cerebral lesions and edematous areas under chronic hypertension. Acta Neurochir Suppl (Wien). 1994;60:265-267.
24. Yamada K, Sakaguchi T, Yuguchi T, Kohmura E, Otsuki H, Koyama T, Hayakawa T. Blood-borne macromolecule induces FGF receptor gene expression after focal ischemia. Acta Neurochir Suppl (Wien). 1994;60:261-264.
25. MacMillan V, Judge D, Wiseman A, Settles D, Swain J, Davis J. Mice expressing a bovine basic fibroblast growth factor transgene in the brain show increased resistance to hypoxemic-ischemic cerebral damage. Stroke. 1993;24:1735-1739.
26. Tenjin H, Anderson RE, Meyer FB. Treatment with basic fibroblastic growth factor following focal cerebral ischemia does not prevent neuronal injury. J Neurol Sci. 1995;128:66-70.
27. Jiang N, Finklestein SP, Do T, Caday CG, Charette M, Chopp M. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion. Stroke. 1995;26:10. Abstract.
28. Hogan MJ, Gjedde A, Hakim AM. In vivo distribution of CGS-19755 within brain in a model of focal cerebral ischemia. J Neurochem. 1992;58:186-191.
29. Brian JE, Traystman RJ, McPherson RW. Changes in cerebral blood flow over time during isoflurane anesthesia in dogs. J Neurosurg Anesthesiol. 1990;2:122-130.
30. Regli L, Anderson RE, Meyer FB. Basic fibroblast growth factor increases cerebral blood flow in vivo. Stroke. 1995;24:165. Abstract.
31. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Gimenez-Gallego G. Hypotensive activity of fibroblast growth factor. Science. 1991;254:1208-1210.
32. Mattson MP, Murrain M, Guthrie PB, Kater SB. Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J Neurosci. 1989;9: 3728-3740.
33. Freese A, Finklestein SP, DiFiglia M. Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity. Brain Res. 1992;575:351-355.
34. Zhang Y, Tatsuno T, Carney JM, Mattson MP. Basic FGF, NGF, and IGFs protect hippocampal and cortical neurons against iron-induced degeneration. J Cereb Blood Flow Metab. 1993;13: 378-388.
35. Nishikawa T, Kirsch JR, Koehler RC, Miyabe M, Traystman RJ. Competitive N-methyl-D-aspartate receptor blockade reduces brain injury following transient focal ischemia in cats. Stroke. 1994;25:2258-2264.